Skip to content
Open access · OA via Europe PMC

Formononetin improved healthspan via the P53/P21/CDK4 pathway in SAMP8 mice and DAF-16/SKN-1 signaling pathway in C.elegans

Liu B, Cui D, Liu J, Xu Y.

Frontiers in pharmacology

Abstract

This study in Frontiers in Pharmacology examines the effects of formononetin on healthspan(definition) using P53/P21/CDK4 pathways in mice and DAF-16/SKN-1 in worms.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
B, L., D, C., J, L., &amp; Y., X. (n.d.). Formononetin improved healthspan via the P53/P21/CDK4 pathway in SAMP8 mice and DAF-16/SKN-1 signaling pathway in C.elegans. <em>Frontiers in pharmacology</em>. https://europepmc.org/article/PMC/PMC13642585
Vancouver
B L, D C, J L, Y. X. Formononetin improved healthspan via the P53/P21/CDK4 pathway in SAMP8 mice and DAF-16/SKN-1 signaling pathway in C.elegans. Frontiers in pharmacology.
BibTeX
@article{liundFormon, title = {Formononetin improved healthspan via the P53/P21/CDK4 pathway in SAMP8 mice and DAF-16/SKN-1 signaling pathway in C.elegans}, author = {Liu B and Cui D and Liu J and Xu Y.}, journal = {Frontiers in pharmacology}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings